Ajanta Pharma Q3

Net sales of the company rose to Rs 356.28 crore for the third quarter as compared to Rs 292.59 crore for the same period of corresponding financial year, Ajanta Pharma Ltd said in a filing to the BSE.

Net sales of the company rose to Rs 292.59 crore for the third quarter, as compared to Rs 225.68 crore in the same period of previous fiscal, Ajanta Pharma Ltd said in a filing to the BSE.

Drug company Ajanta Pharma today reported 75.95 per cent increase in net profit to Rs 32.57 crore for the third quarter ended December 31, 2012, mainly on robust sales. The company had posted a net profit of Rs 18.51 crore for the corresponding period previous fiscal year.

Net sales of the company rose to Rs 356.28 crore for the third quarter as compared to Rs 292.59 crore for the same period of corresponding financial year, Ajanta Pharma Ltd said in a filing to the BSE.

Net sales of the company rose to Rs 292.59 crore for the third quarter, as compared to Rs 225.68 crore in the same period of previous fiscal, Ajanta Pharma Ltd said in a filing to the BSE.

Drug company Ajanta Pharma today reported 75.95 per cent increase in net profit to Rs 32.57 crore for the third quarter ended December 31, 2012, mainly on robust sales. The company had posted a net profit of Rs 18.51 crore for the corresponding period previous fiscal year.